Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a Tripartite Interaction by Palacios Ortega, Juan et al.
Accepted Manuscript
Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a Tripartite Interaction
Juan Palacios-Ortega, Sara García-Linares, Esperanza Rivera-de-Torre, José G.
Gavilanes, Álvaro Martínez-del-Pozo, J.Peter Slotte
PII: S0006-3495(19)30393-5
DOI: https://doi.org/10.1016/j.bpj.2019.05.010
Reference: BPJ 9693
To appear in: Biophysical Journal
Received Date: 15 March 2019
Accepted Date: 10 May 2019
Please cite this article as: Palacios-Ortega J, García-Linares S, Rivera-de-Torre E, Gavilanes JG,
Martínez-del-Pozo Á, Slotte JP, Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a
Tripartite Interaction, Biophysical Journal (2019), doi: https://doi.org/10.1016/j.bpj.2019.05.010.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a 
Tripartite Interaction. 
 
Juan Palacios-Ortega†‡, Sara García-Linares†ǁ, Esperanza Rivera-de-Torre†, José G. 
Gavilanes‡, Álvaro Martínez-del-Pozo‡* and J. Peter Slotte†* 
† Departamento de Bioquímica y Biología Molecular, Universidad Complutense, 
Madrid 28040, Spain 
‡ Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, 20500 
Turku, Finland 
ǁPresent address: Cell Biology Department, Harvard Medical School, Boston, MA 02115, 
USA 
 
 
*Corresponding authors: Dr. Álvaro Martínez-del-Pozo (alvaromp@ucm.es ) and Dr. 
J.Peter Slotte (jpslotte@abo.fi) 
 
Short title: Properties of sticholysin 
 
 
 
 
 
 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
ABSTRACT 
Actinoporins are a group of soluble toxic proteins that bind to membranes containing 
sphingomyelin (SM) and oligomerize to form pores. Sticholysin II (StnII) is a member 
of the actinoporin family, produced by Stichodactyla helianthus. Cholesterol (Chol) is 
known to enhance the activity of StnII. However, the molecular mechanisms behind this 
activation have remained obscure, although the activation is not Chol specific but rather 
sterol specific. To further explore how bilayer lipids affect or are affected by StnII, we 
have used a multiprobe approach (fluorescent analogs of both Chol and SM) in 
combination with a series of StnII tryptophan (Trp)-mutants, to study StnII/bilayer 
interactions. First we compared StnII bilayer permeabilization in the presence of Chol 
or oleoyl-ceramide (OCer). The comparison was done since both Chol and OCer have a 
1-hydroxyl which help to orient the molecule in the bilayer (although OCer have 
additional polar functional groups). Both Chol and OCer also have increased affinity for 
SM, which StnII may recognize. However, our results show that only Chol was able to 
activate StnII-induced bilayer permeabilization – OCer failed to active. To further 
examine possible Chol/StnII interactions, we measured Förster resonance energy 
transfer (FRET) between Trp in StnII and cholestatrienol (CTL), a fluorescent analog of 
Chol. We could show higher FRET efficiency between CTL and Trp:s in position 100 
and 114 of StnII, when compared to three other Trp positions further away from the 
bilayer binding region of StnII. Taken together, our  results suggest that StnII was able 
to attract Chol to its vicinity, maybe by showing affinity for Chol. SM interactions are 
known to be important for StnII binding to bilayers, and Chol is known to facilitate 
subsequent permeabilization of the bilayers by StnII. Our results help to better 
understand the role of these important membrane lipids for the bilayer properties of 
StnII. 
 
 
Statement of significance 
Sticholysin II (StnII) is a pore-forming toxin which interacts with sphingomyelin in 
target membranes. Cholesterol is known to modulate pore formation. In our study we 
examine in detail the molecular interactions between StnII and both pyrene-
sphingomyelin and cholestatrienol, a fluorescent cholesterol analog. We show that both 
lipids intract with StnII in the bilayer. Using Trp-mutants of StnII, we also obtained 
information about which Trp residues cholesterol preferentially interacted with. Our 
findings provide new details to the process of StnII pore formation, as influenced by 
sphingomyelin and cholesterol.  
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INTRODUCTION 
Pore-forming toxins (PFTs) constitute an important family of membrane-binding 
proteins. In solution, PFTs are monomeric and behave like globular proteins, with a 
defined stable conformation. When PFTs encounter membranes with certain lipid 
compositions, these proteins are capable of forming pores that cause an osmotic shock 
in the targeted cells (1, 2). The proteins undergo a molecular metamorphosis that allows 
the PFTs not only to bind but also to oligomerize and transform into integral membrane 
proteins. Therefore, these proteins are also called metamorphic or amphitropic proteins 
due to this dual behavior (3-6). PFTs can assemble into structures inserted across the 
bilayer to form pores. This process occurs without covalent modification of the 
polypeptides involved, but also without coupling to any other chemical reaction, 
although the overall process must be thermodynamically favorable. Taken together, 
these facts suggest that this family of proteins constitutes a very good model for 
studying the molecular mechanisms that allow the transition from an aqueous medium 
to the hydrophobic environment of biological membranes. Sea anemone actinoporins 
are PFTs that are an optimal system of study, given their structural and functional 
features (6-8). 
Actinoporins constitute multigenic families that have been detected in more than 
20 sea anemone species (6, 9-11). However, only four species have been characterized 
in great detail. They are sticholysins I and II (StnI and StnII, respectively) from 
Stichodactyla helianthus (6-8), equinatoxin II (EqtII) from Actinia equina (11, 12), and 
fragaceatoxin C (FraC) from Actinia fragacea (13). All show very similar amino acid 
sequences and almost identical monomeric and water-soluble three-dimensional 
structures (14-19), displaying a β-sandwich motif composed of 10−12 β-strands flanked 
by two α-helices that interact with both sides of the β-sandwich (Figure 1A) (14-19). 
One of these helices (α1) is located at the N-terminal end, and it is responsible for the 
function of the protein. After binding to the membrane, the helix extends to the first 30 
residues and inserts into the membrane to form the walls of the pore (Figure 1B) (14, 
20-26). 
The incorporation of actinoporin into the membrane, and the subsequent pore 
formation, depends largely on the composition of the lipid bilayer and physicochemical 
properties (12, 24, 27-35). Sphingomyelin (SM) is required (30, 36-38), but other 
conditions in the bilayer membrane (such as the presence of sterols, the coexistence of 
various phases or domains, lateral packing, fluidity, membrane thickness, and the 
strength of the interfacial hydrogen bonding network) have a strong influence on the 
pore-forming ability of the proteins (24, 25, 30, 32-35, 39-45). In this context, 
cholesterol (Chol) greatly influences the pore-forming mechanism considered as a 
whole (24, 25, 32, 35, 44-48). However, the specific role of Chol remains elusive. 
It has been shown that in some conditions the Chol-induced formation of lipid 
phase boundaries may enhance pore formation by actinoporins (40, 41, 43, 49). 
However, using 18:1-SM (OSM) bilayers we have also shown that StnII does not 
require those phase boundaries for pore formation (24). The results also suggested that 
as the lateral packing among the SM chains became tighter, and the strength of the 
hydrogen bonds increased, pore formation was hindered (24, 34). It has also been 
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observed that fatty acid alcohols (50), and even benzyl alcohol (24), facilitate pore 
formation by actinoporins. It was proposed that these alcohols interfere with 
intermolecular hydrogen bonding among SMs, lowering the energy barrier for the 
diffusion of monomeric actinoporins and oligomerization to constitute a pore (24, 34, 
50). Further confirmation of the hypothesis involving hydrogen bonding arose from the 
observation that the presence of dihydro-SMs (which lack the trans ∆4 double bond of 
the long-chain base) (34) strongly impaired toxin binding and pore formation. This 
effect of establishing a tighter hydrogen bonding network was easily reverted by the 
presence of Chol. It has been established that many different Chol analogs have a very 
strong effect on the functionality of actinoporins, facilitating actinoporin-induced 
membrane permeabilization (24). Given that all the sterols assayed had a 3β-OH group 
in common, these results seemed to confirm the hypothesis about the strong influence of 
intermolecular hydrogen bonding in SM bilayers (34), without disregarding the other 
possibilities of sterols influencing membrane fluidity and SM clustering. Furthermore, 
cholesterol appears to affect the SM phosphocholine head group orientation and 
dynamics similarly as seen with glycerophospholipids (51-54), which could facilitate 
the interaction between actinoporins and SM. Finally, some authors have also suggested 
that Chol is required for the insertion of the N-terminal α-helix of EqtII into the core of 
the membrane, enabling the constitution of a fully functional pore (46). 
Among all well-known actinoporins, StnII seems to be especially sensitive to the 
presence of Chol (35). Therefore, in the present work, we examined this actinoporin 
with the aim of shedding further light on our understanding of the role of Chol in pore 
formation. The results support the need for preferred SM distribution in the membrane 
for optimal pore formation and the role of Chol in facilitating this distribution. Using a 
set of tryptophan (Trp) mutants, we also show the specific approach of StnII to Chol in 
the pore structures. 
 
MATERIALS AND METHODS 
Materials 
Calcein and cholesterol were obtained from Sigma-Aldrich (St. Louis, MO). Egg 
sphingomyelin (eSM), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC), and 1-palmitoyl-2-(7-doxyl)-stearoyl-
phosphatidylcholine (7-SLPC) were obtained from Avanti Polar Lipids (Alabaster, AL). 
Palmitoyl SM (PSM) was isolated from eSM with preparative high-pressure liquid 
chromatography, as described previously (55). N-C10-pyrene-D-erythro-sphingomyelin 
(PyrSM), oleyl-ceramide (OCer), and cholestatrienol (CTL) were synthesized and 
purified in-house using published procedures (56). Wild-type StnII, and the different 
Trp mutants employed, was produced in Escherichia coli RB791 and purified to 
homogeneity as described previously (57, 58). 
 
Preparation of vesicles 
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Briefly, vesicles were made by extruding resuspended dried lipid films as described 
previously (24-26, 34). Lipid films were made from a methanol mixture of the desired 
lipids dried under nitrogen flow. This film was later kept in a vacuum for at least two 
hours to ensure complete elimination of the organic solvent. Specific details for each set 
of experiments are provided in the following sections. 
 
Release of calcein from large unilamellar vesicles 
Calcein-entrapped large unilamellar vesicles (LUVs) were prepared from different 
lipids by extrusion through 200 nm filters at 60 °C as previously described (38). The 
buffer used was Tris buffer (10 mM Tris, 140 mM NaCl, pH 7.4) containing calcein at 
100 mM. The LUVs were used for permeabilization studies within 8 h. The specific 
compositions of the LUVs are indicated in the corresponding sections or figure legends. 
The LUV and StnII concentrations during the calcein leakage experiments were 2.5 µM 
and 20 nM, respectively, unless otherwise indicated. Emission at 550 nm was followed 
at 23 °C as a function of time (the excitation wavelength was 480 nm). Fluorescence 
emission was measured in a FLUOstar OPTIMA microplate reader (BMG-Labtech, 
Ortenberg, Germany). The fraction of calcein released was determined based on the 
maximum calcein release that was induced by LUV disintegration using 10% Triton X-
100. To ensure that no spontaneous leakage occurred, the emission was measured for 
each sample for 3−5 min before the toxin was added. A steady signal level, indicating 
intact vesicles, was observed for all samples. 
 
Measurement of the excimer/monomer ratio of PyrSM in bilayer systems 
For measurement of the excimer/monomer (E/M) ratio, POPC:PSM:PyrSM (5:3:2), 
POPC:PSM:PyrSM:Chol (5:3:2:1), or POPC:PSM:PyrSM:OCer (5:3:2:1) LUVs were 
prepared. The experiments were carried out at 23 ºC. The final E/M ratio was 
determined 10 min after StnII was added. The initial E/M ratio also recorded. The final 
phospholipid concentration was around 1.0 µM in all experiments shown. The exact 
value was quantified a posteriori with phosphorous determination, using Rouser’s 
method (59), and was then taken into account to calculate the respective protein/lipid 
molar ratios. PyrSM was excited at 345 nm; the monomer emission was read at 392 nm, 
while the excimer emission was monitored at 480 nm. These, as well as subsequently 
referred steady-state fluorescence measurements, were made using a PTI Quanta- 
Master spectrofluorimeter (Photon Technology International, Inc. NJ, USA). 
 
Analysis of CTL fluorescence emission in presence of phase-selective quencher 
The steady-state fluorescence emissions were measured essentially as described 
previously (35, 58, 60-64). Briefly, 1-Palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-
phosphocholine (7SLPC) is a phosphatidylcholine (PC) analog that contains one bulky 
doxyl group in the sn-2 acyl chain. The doxyl group acts as the collisional quencher for 
CTL. Due to the bulkiness of the doxyl group, 7-SLPC is largely excluded from the 
ordered domains in the bilayer, and instead, is enriched in the liquid-disordered phase of 
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the membrane. For that reason, the membrane compositions used for the samples aimed 
to monitor the quenched emission intensity (F ) were POPC:7-SLPC:PSM:CTL 
50:30:20:5 and POPC:7-SLPC:PSM:CTL 30:20:50:5. That way, two different 
conditions were tested: one in which most CTL would be already protected from the 
quencher by partitioning into the ordered domain (induced by the high amount of PSM) 
and one in which the extension of the ordered domain was smaller, and CTL would be 
more accessible to 7-SLPC. To measure the emission in the absence of a quencher, 7-
SLPC was replaced by POPC in all samples from which unquenched emission intensity 
was measured (F0). All other components were kept constant. The CTL content was 
kept slightly below 5 mol% to avoid self-quenching (65). Emission at 400 nm was 
continuously recorded using 310 nm as the excitation wavelength. This value was 
selected to achieve the maximum excitation of CTL while simultaneously avoiding 
significant excitation of the Trp residues of the proteins. Any Trp-derived emission was 
subtracted before the subsequent calculations. The lipid concentration was always 
around 1 µM in all samples. The exact value was determined a posteriori as described 
above (59). Different amounts of toxin were added after 100 s of a steady signal level of 
the CTL emission was recorded. The emission increased and reached a plateau after the 
toxin was added within less than 100 s in all assays. 
StnII-induced protection of CTL from 7-SLPC-induced quenching was 
determined by obtaining the F/F0 ratios of each pair of comparable samples at all times. 
The toxin was added to the F and F0 samples to compare the effect of StnII on CTL in 
the presence and absence of 7-SLPC. ∆(F/F0) after the toxin was added was calculated 
to show the decreased exposure of CTL to the quencher in the presence of the 
actinoporin, as well as the larger increased quantum yield of CTL when 7-SLPC was 
present in the membrane. 
 
Fluorescence emission from the proteins assayed in the presence of lipid vesicles 
The fluorescence emission of the different StnII variants was recorded between 280 and 
500 nm. Excitation was set to 260 nm to minimize the direct contributions of CTL in the 
emission (see the following section). The StnII concentration was 200 nM. Emission 
spectra were recorded repeatedly after every four additions (two in the final step) of 
small aliquots of vesicles, each addition giving an increment of 1.3 µM lipid 
concentration, up to a final lipid concentration of 18.5 µM (92.6 L/P ratio). Equivalent 
samples, in the absence of the toxin, were used to correct for light scattering 
contributions to the final emission. The areas used to calculate the relative quantum 
yield were obtained by numerical integration of the recorded spectra. The lipid 
composition employed was DOPC:eSM:Chol 1:1:1 to ensure binding of the Trp 
mutants, given that some show low affinity to vesicles containing a lower percentage of 
Chol (58). 
 
Measurements of Förster resonance energy transfer from StnII to CTL 
The StnII and CTL fluorescence emissions were recorded as described in the previous 
section. The vesicles had the following composition: DOPC:eSM:sterol (1:1:1), where 
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sterol stands for the total amount of Chol + CTL. The mol% of CTL was increased 
while the amount of Chol was reduced to keep the sterol mol% constant in the 
membrane. An equivalent sample, without protein added, was used in all experiments to 
obtain the background contribution of CTL and light scattering. The Förster resonance 
energy transfer (FRET) efficiencies were calculated by adjusting the emission of the 
corresponding toxin in the presence of an equivalent amount of DOPC:eSM:Chol 
(1:1:1) membranes to that of the same toxin in the presence of membranes that 
contained CTL. The adjustment was performed by non-linear least squares fit of the 
emission between 325 and 340 nm, which contains only the Trp emission. Subtraction 
of the fitted spectra from the spectra recorded in the presence of CTL yielded the 
contribution of CTL to the final emission. A very small peak centered between 300 and 
310 nm, corresponding to the unquenched Tyr emission in the presence of CTL, was 
also obtained. The energy transfer efficiency was calculated as the factor needed to 
adjust the unquenched spectra to the quenched spectra. 
Preferential distribution of CTL around StnII was determined using the StnII 
mutant StnII W43/110/114/115F, which contains only a single Trp residue (58), 
according to a model previously described (66, 67). The FRET efficiencies were 
calculated as specified in the previous paragraph. The fluorescence emission decay was 
measured using a FluoTime 100 spectrofluorimeter with a TimeHarp260 pico time-
correlated single-photon-counting module (PicoQuant, Berlin, Germany). The tPA was 
excited with a 297 ± 10 nm LED laser source (PLS300, PicoQuant), and the emission 
was collected through a 435/40 nm single-band pass filter. Fluorescence decays were 
recorded at 23o C (temperature controlled by water bath) with constant stirring during 
measurements. Data were analyzed using FluoFit Pro software obtained from 
PicoQuant.  
According to the location of the Trp146 residue in the three-dimensional 
structure of StnII, and the expected orientation of the protein in the membrane based on 
previously obtained oligomeric structures (19), the energy transfer to the trans leaflet 
can be considered negligible. Due to the particular geometric configuration of the StnII–
membrane system and the position of Trp146 in the system, we used only the part of the 
model that describes the FRET to acceptors in the trans leaflet to predict the effective 
FRET from that Trp residue to the CTL molecules in the cis leaflet of the membrane. 
The fundamental reason is that in this model, the part that models the FRET to the cis 
leaflet accounts for the FRET from donors to acceptors in the same diffusion plane, 
whereas the part that describes the FRET to the trans leaflet accounts for the FRET 
from donors to acceptors that are in a separate, parallel diffusion plane. Briefly, the 
model is used to calculate what the efficiency of the energy transfer would be for a 
given donor acceptor pair, which is unlinked and randomly distributed in the membrane, 
according to the Förster distance (R0) of the pair, the exclusion radius of the acceptor 
around the donor (Re), the surface density of the acceptor in the membrane (n), and the 
distance between the diffusion planes of the donors and the acceptors (h). 
The Förster distance of this particular FRET pair was calculated as described 
(68), using the following expression: 
 = 0.2108(
(/,  [1] 
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which yields the Förster distance in Å, and where κ2 is the orientation factor, n is the 
refractive index, QD is the quantum yield of the donor, and J(λ) is the overlap integral 
between the donor’s emission spectra and the acceptor’s absorption spectra. The 
orientation factor κ2 was considered to be 2/3, which represents the dynamic isotropic 
limit. This value is often used for experiments in membranes (69, 70). The refractive 
index n was set to 1.39, which is the average between nwater and the estimated values for 
nmembrane. The use of nwater represented an increase of only about 3% in the Förster 
distance. The quantum yield of Trp146 was assumed to be 0.14, which is the quantum 
yield of Trp in water (71). Variations of the QD value down to 0.1 or up to 0.2 
represented only an approximate 6% change compared to the value used for QD  (0.14) 
in the final R0 value. The overlap integral J(λ) was calculated as 
( =  (( ,  [2] 
where FD is the donor’s emission spectra with its area normalized to 1, and εA is the 
acceptor’s absorption spectra in M–1 cm–1 units. The R0 value was 22.9 Å. 
The time-dependent probability of remaining unquenched of the donor decay in 
the presence of unlinked, randomly distributed acceptors in a separate diffusion plane 
was derived in reference (72): 
 !(" = exp #−2%ℎ'  (1 − exp )− *+,+-.
 * /〈1〉. 345 363
7
 8,  [3] 
where h is the distance between the diffusion planes of the donors and acceptors, m is 
the surface density of the acceptor, and Re is the exclusion radius between the donor and 
the acceptor’s projection in the donor diffusion plane. The topological parameter α is 
defined as 3 = ℎ √ℎ + ;⁄ , where r is the distance between the donor and the 
projection of the acceptor in the donor’s diffusion plane. The parameter ω is a particular 
case of α, at which r = Re, which is the maximum possible value of α. 
According to the published structure of the FraC pore (18), h was considered to 
be 26–28 Å from the equivalent rp to Trp146 to the location of Chol molecules in a 
bilayer. For the exclusion distance Re, a range of possible values were considered, 
including the extreme case of 0 Å, which would indicate that the acceptor was located 
right below the donor. The surface density of CTL (m) in the bilayer was calculated 
from its mole fraction in the bilayer using areas per lipid molecule of 48 Å2 for POPC in 
the presence of 0.3 mol% of sterol (73), 47.4 Å2 for PSM (74), and 37.7 Å2 for CTL 
(67, 73). 
The decay of the donor in the presence of the acceptor in the cis leaflet is given 
by =(" = =(" !(". The theoretical FRET efficiency is then calculated as 
> = 1 −  ?@(/ABCDE(/
F
, d/
 ?@(/F, d/
,  [4] 
where ID(t) represents the decay of the donor in the absence of the acceptor. For 
randomly distributed donors and acceptors, experimental results would lie on the 
theoretically predicted line. However, if the acceptor is preferentially distributed near 
the donor, the observed FRET efficiencies would be greater than the theoretical values, 
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as if the R0 were larger, although what actually happens is that the average donor–
acceptor distance is smaller than expected for a random distribution. The same 
reasoning, with opposite effects, is valid for acceptors that are excluded from the 
vicinity of the donor. 
 
RESULTS 
StnII causes similar PyrSM declustering regardless of the presence of Chol or 
OCer 
Clustering of pyrene-labeled lipids between different bilayer domains can be studied by 
measuring the pyrene excimer/monomer (E/M) emission ratio (75-77). Therefore, 
PyrSM was employed to study the effect of StnII on SM-cluster dispersion. In addition 
to using Chol, we opted to also test OCer for the following reasons. Oleoyl-ceramide 
(OCer) is a lipid that, as Chol, is prone to interact with SM. The unsaturation in the acyl 
chain of this ceramide species prevents it, however, from forming gel phases in the 
range of temperatures that were used. This is particularly important since, as has been 
shown before (45), gel phase formation hinders the activity of StnII. OCer displays two 
molecular features which are of interest for the work presented herein. First, its 
mentioned ability to interact with SM without forming gel phases (24, 34) and, second, 
the presence of its interfacial hydroxyl group. This (C1)OH is in a similar location 
relative to the membrane to that of cholesterol. By comparing the effect of OCer and 
cholesterol on StnII behavior, we aimed to ascertain if either of these characteristics are 
the ones that influence cholesterol’s property as a StnII’s activator. 
It is known that SM molecules tend to cluster in equimolecular mixtures of 
POPC (78). As shown in Figure 2, a high E/M ratio value of 3.45 was obtained in these 
conditions. The inclusion of OCer or Chol in the vesicles resulted in a considerable 
reduction in the ratio. The values decreased to 2.78 and 2.38 in the vesicles containing 
9.1 mol% of OCer or Chol, respectively (Figure 2). This result shows that both lipids 
can intercalate among SM molecules, thus diminishing the direct Pyr–Pyr interactions 
that result in excimer emission. Accordingly, Chol would be a slightly better 
intercalator than OCer. This result might also be related to the documented (24, 25, 32, 
35, 43-49) improvement in StnII activity observed in the presence of Chol. 
Addition of StnII also resulted in a further decrease in the E/M ratio, although 
the decrease followed a protein concentration dependence that was practically 
independent of the presence of OCer or Chol (Figure 2). Thus, the StnII-induced 
reduction in Pyr–Pyr contacts could be caused by StnII itself intercalating some residue 
between the Pyr groups, or by StnII-induced intercalation of other lipids among the Pyr-
SM:s. 
 
Chol is a better enhancer of the activity of StnII than OCer 
One of the questions that remains unsolved is whether the Chol-enhancing effect of 
actinoporin action (24, 25, 32, 35, 43-49) is a major consequence of the formation of 
lipid boundaries within the membrane, due to the existence of liquid-ordered (Lo) 
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phases, or whether it is the result of other effects of Chol. As stated in the Introduction 
section, it has been shown that lateral packing or clustering of SM is important (as also 
observed in the present work; see Figure 2) and how distortion of the SM hydrogen 
bonding network has a profound effect on actinoporin activity (24, 34, 50). To further 
test this hypothesis, calcein leakage experiments were carried out. We first used 
DOPC:SM (80:20) LUVs that contained increasing amounts of either Chol or OCer. 
Both lipids showed a high affinity for SM, intercalating between SM molecules (Figure 
2), and contained a hydroxyl group whose location at the bilayer/aqueous interphase 
was similar. It is possible that this interfacial hydroxyl can distort the intermolecular 
hydrogen bonding network of SMs. OCer, however, did not participate in creating 
defined liquid-ordered domains with SM as Chol can do (79).  
As seen in Figure 3, Chol greatly increased the release rates for calcein even 
when present at a low percentage. The effective Chol concentration was probably below 
the threshold needed for the formation of Chol-induced lipid domains (80). However, 
OCer failed to activate StnII-induced release of calcein (Figure 3). The effect of Chol 
was noticeably more pronounced, perhaps due to its particular structure. Interestingly, at 
20 mol% Chol, where the Ld/So phase boundary appears, no further increase in Chol-
promoted activation was observed. In both cases, these enhancing effects became stable 
when the proportions employed were 80:20:7.5, that is, for an amount of Chol slightly 
smaller than approximately 7 mol%. 
 
StnII changes the CTL microenvironment 
Partitioning of a fluorescent probe between fluid and ordered membrane domains can be 
determined by using a phase-selective quencher (81). With the aim of studying the 
effect of StnII on membranes that contain SM and Chol, the fluorescent Chol-analog 
CTL was used as a probe (56, 65, 82), whereas 7-SLPC was chosen as a phase-selective 
collisional quencher (Figure 4). The gel-to-liquid phase transition temperature of 7-
SLPC has been determined to be approximately 8 °C (83), and thus, this lipid is in the 
fluid state at 23 °C, the temperature at which the experiments were carried out. 
POPC:7-SLPC:PSM:CTL (50:30:20:5) vesicles were employed. At this 
concentration, CTL is not self-quenched. The sterol content was similar to that showing 
the maximum enhancement in the release rate of calcein in Figure 3. In this situation, 
the recorded initial F/F0 value was 0.27, revealing that most of the CTL was accessible 
to the quencher (Figure S1). The addition of StnII induced an increase in the observed 
F/F0 value that revealed how StnII exerted a considerable quenching-protection effect 
on CTL (Figure 4). Given that the quencher is known to partition preferentially into the 
fluid phase, these results can be interpreted as the protein reducing CTL contacts with 
fluid-phase lipids, no longer available for 7-SLPC quenching. If StnII binds CTL, it 
could also be that the bound CTL is protected by the protein, and not only that StnII 
redistributes CTL more to the SM phase. In the absence of 7-SLPC, StnII caused an 
increase in the CTL quantum yield, most probably by shielding it from water. Overall, it 
seems that the most probable interpretation is that when 7-SLPC is present, StnII 
produces a change in the lipids surrounding CTL. When the vesicles employed were 
POPC:7-SLPC:PSM:CTL (30:20:50:5), where the SM proportion was much higher 
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(nearly approximately 50 mol%), this effect was greatly reduced (Figure 4). Higher 
PSM content decreases the extent of the phase boundary as a consequence of the larger 
domains. This is reflected in the initial F/F0 value (0.78); implying CTL is already 
shielded from the quencher. The interaction of StnII with the membrane is expected to 
be essentially the same, in terms of activity and affinity, to that in the previous scenario. 
In this new situation, CTL protection from the quencher was modest (Figure 4). This 
expected result confirmed that in SM-rich bilayers, most CTL is not accessible to 7-
SLPC, due to the preferential partitioning of CTL into the ordered phase and its 
preferred interaction with PSM. 
 
StnII Trp side chains move to a more hydrophobic environment in the presence of 
vesicles that contain SM and Chol 
To study the presumed closeness between StnII and Chol in membranes that contain 
SM, the FRET between Trp residues in StnII and CTL was the chosen approach. Energy 
transfer suggests the establishment of very close StnII–Chol interactions. A collection 
of Trp-to-Phe mutants, which had been characterized in a previous work (58), was 
available. The protein variants assayed were the wild-type protein (StnII WT), a single 
mutant (W43F), two double mutants (W43/110F and W43/114F), one triple mutant 
(W43/110/114F), and one quadruple variant (W43/110/114/115F) (Figure 1). This 
quadruple mutant contained only a single Trp, specifically W146. 
First, titration of the different StnII variants with increasing amounts of 
DOPC:eSM:Chol (1:1:1) LUVs was performed (Figure 5). DOPC was used instead of 
POPC because the Trp-mutants employed had already been characterized in this system, 
in which we already knew that they displayed a considerable membrane binding (53). 
This vesicle composition, containing a large proportion of Chol, was indeed needed due 
to the low affinity of some of the Trp mutants employed for the membranes that 
contained low amounts of this sterol (58). In all experiments, the fluorescence emission 
spectra of the proteins displayed a considerable increase in the quantum yield (Figure 5, 
right column), a blue-shift in the emission maximum, and a reduction in the spectral 
width (Figure S2). The first two are expected features of Trp side chains entering a more 
hydrophobic microenvironment. The third one can be also explained as Trp residues 
changing from varied environments to a relatively equal, non-polar environment. The 
observed increases in the quantum yield suggest that W110 and W114 were responsible 
for most of the effects observed. Representation of the relative change in the quantum 
yield as a function of the lipid/protein molar ratio (L/P ratio) showed how saturation 
was reached at similar L/P ratios (Figure 5, right column) for StnII WT, W43F, and 
W43/110F mutants. W43/114F reaching saturation at a higher L/P ratio confirmed, as 
previously described using isothermal titration calorimetry, that W114 is more 
important for membrane affinity than W110, although W110 is more exposed to the 
aqueous phase than W114 when the protein is in solution (58). Accordingly, 
substitution of both Trp residues by Phe produced variants where the quantum yield was 
barely increased (see the results for the triple and quadruple Trp mutants in Figure 5). 
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CTL is located near StnII Trp residues 110 and 114 
The same StnII variants were titrated with other vesicles at the DOPC:eSM:sterol ratio 
of 1:1:1, but contained 5 mol% CTL. Non-radiative energy transfer from the Trp side 
chains to this fluorescent version of Chol was clearly observed (Figure 6). This result 
suggested that the indole moiety of these amino acids was in close proximity to CTL 
molecules to be able to produce the observed effect. Again, the FRET was especially 
relevant for proteins containing Trp residues 110 and 114 (Figure 6). Representation of 
the CTL emission originated from the FRET as a function of the L/P ratio led to the 
same conclusion, and further confirmed the previous observation that saturation was 
reached at very similar lipid concentrations in all experiments (Figure S3). Again, 
substitution of Trp110 and Trp114 for Phe rendered proteins that were capable of less 
energy transfer to CTL (W43/110/114F and W43/110/114/115F in Figures 6 and 7). 
 
There is preferential distribution of Chol near StnII 
Among all 20 canonic protein amino acids, Trp stands out because of the properties of 
its side chain. The indole ring is not only the bulkiest side chain group but also provides 
the potential to interact with various molecules. It is a rigid planar ring, which can 
establish a wide variety of very different interactions with other groups, including 
hydrogen bonding, dipolar or cation-π interactions, and hydrophobic effects (64, 84-87). 
Given that Chol also has a complex and hydrophobic rigid ring structure, it could 
interact with the indole ring of Trp. 
To resolve whether Chol is preferentially distributed near StnII, an approach 
previously described by Holt et al. (67) was used. A mutant containing only one Trp, 
the StnII-W43/110/114/115F mutant, was used to avoid complications with the 
application of the model employed. This single Trp variant appeared to be one of the 
few soluble StnII mutants containing only one Trp residue. Furthermore, this remaining 
Trp did not seem to be directly involved in protein–lipid interactions, as shown in 
Figure 5 and by García-Linares et al. (58). Instead, Trp146 appears to be needed for 
protein–protein interactions that lead to oligomerization and pore formation (Figure 1) 
(19, 58). The increase in the quantum yield observed for this quadruple Trp to Phe 
mutant is interpreted as the side chain of Trp146 entering a hydrophobic cavity in the 
neighboring actinoporin monomer in the final pore structure (19). 
According to the model used (67), if the acceptor (CTL) is randomly distributed 
around the donor, the experimental FRET efficiencies are located on the theoretical 
FRET efficiency curve. If the acceptor is preferentially distributed near the donor, the 
experimental values are located above it, because of the reduced average distance 
(which still must be larger than the exclusion distance). The plot representing the 
empirically determined energy transfer efficiencies, at several different surface densities 
of CTL (dots in Figure 7), versus the theoretical curves for the expected energy transfer 
(lines in Figure 7), shows that the experimental data were higher than the calculated 
efficiencies. This conclusion is supported even considering that CTL can be located 
right below the donor (Re = 0 Å), while also at the shortest estimated possible distance 
from Trp146. 
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This result indicates that CTL is preferentially distributed near StnII. Given that 
the sterol effect on this protein’s activity has been shown to be largely independent of 
the sterol structure (24), this result can also be extrapolated to Chol. 
 
DISCUSSION 
The presence of Chol in bilayer membranes affects several membrane properties which 
can influence the function and distribution of membrane proteins. Chol has an ordering 
effect on acyl chains of surrounding phospho- and sphingolipids which results in more 
condensed bilayers. It is also well-known that Chol displays high affinity for SM when 
embedded in a biological membrane (54, 88). This observation explains the existence of 
SM- and Chol-rich Lo domains. Accordingly, it has been proposed that the presence of 
lipid domains in the membrane could explain the observed effects of Chol on 
actinoporin activity. The results presented here show that StnII induced activation of the 
calcein release phenomenon starts to be observable at a mol% of Chol below the 
minimum amount needed for SM and Chol to arrange into distinct lipid domains (80) 
(Figure 3). Furthermore, qualitatively speaking, OCer, another good SM intercalator 
(Figure 2), does not show such behavior (Figure 3).  
 SMs form extensive intramolecular hydrogen bonds (from the 3OH of the long-
chain base to phosphate oxygens of the head group), but also intermolecular hydrogen 
bonding involving the NH of the long-chain base are important for sphingomyelin (and 
sphingolipid) properties in membrane environments (89. Similar hydrogen bonds cannot 
be established among glycerophospholipids. Hydrogen bonding involving SM has been 
also shown to markedly stabilize interactions with both Chol and ceramide in fully 
hydrated bilayers (90). We have demonstrated before (24, 45) that the existence of a 
fluid phase is important for the formation of pores by actinoporins. These results, 
combined with the use of benzyl alcohol and several different sterols, suggested that 
these compounds enhance StnII action by modifying the SM interfacial hydrogen 
bonding network (24, 34). This effect was interpreted as leading to a more favorable 
distribution of SM molecules in the membrane and to easier availability to StnII 
molecules. 
 Chol and OCer share an interfacial hydroxyl group as a common feature. Its 
location enables hydrogen bonding with other lipid head groups, especially with SM. 
Thus, both OCer and Chol could potentially interfere with the hydrogen bonding 
networks formed by SMs, although they are likely to disturb the network differently, as 
OCer has more possibilities to form hydrogen bonds compared to Chol. Another 
consequence of the arrangement of Chol in the membrane is that membrane domains 
with increased Chol content (i.e., lipid rafts), can have an increased bilayer thickness. 
This agrees with the observation that Chol is not only required for complete membrane 
penetration by actinoporins (46) but also for optimizing membrane thickness for StnII 
action (25). Our results here show, however, that the presence of an interfacial (C1)OH 
group is not enough to explain the observed effect of Chol-enhancing StnII activity, 
because OCer, with a similar (C1)OH group, does not induce a comparable effect. Since 
OCer has an unsaturated acyl chain, its molecular volume requirement in bilayers is 
larger than that of cholesterol. This implies that lateral packing is more dense in 
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Chol/SM domains or small clusters (condensing effect) than it is in OCer/SM domains 
or clusters. Such differences in lateral packing in the SM-rich domains could affect SM 
head group orientation differently, and explain why cholesterol does and OCer does not 
activate StnII-induced bilayer permeabilization.  
It has been shown that mixtures in which 1,2-dimyristoyl-sn-glycero-3-
phosphocholine is in molar excess over PSM hinder SM to participate efficiently in the 
StnII-induced pore formation process (24). Considering that DMPC displays near-ideal 
miscibility with PSM, this observation was interpreted as StnII needing small clusters of 
SM in order to oligomerize and form pores. Building on previous work in which we 
used PyrSM to show that StnII causes SM declustering (24), in this work, we used 
PyrSM to test the effect of the presence of Chol or OCer on SM distribution. The results 
showed that both Chol and OCer could decluster Pyr-SM similarly, although Chol was 
slightly more efficient. However, based on the Pyr-SM results, it is difficult to argue 
whether or not SM head group orientation or presentation to the StnII was markedly 
different during Chol induced SM declustering compared to OCer induced SM 
declustering. 
A question can be raised whether Chol-induced lipid re-arrangement is sensed 
by the toxin, or induced by it. According to the results shown in Figure 4, the answer to 
this question seems to be, at least partially, the latter. StnII binding to the membrane 
resulted in a reduction in the contact of CTL with fluid-phase lipids, which could be 
caused by the effective removal of CTL molecules from the fluid phase. Presumably, 
lipids from the more ordered domain, essentially SM (Figure 4), would then surround 
CTL. However, in the presence of a large amount of SM, the preferential partitioning of 
Chol (in this instance, CTL) into the ordered phase was more noticeable, as seen in the 
high initial F/F0 values. Therefore, the observable effect in the CTL distribution after 
the addition of the toxin was small, indicating that the SM–CTL arrangement was better 
for StnII action in this case. These results suggest that StnII induced a rearrangement of 
CTL distribution in the membrane, probably by recruiting CTL to the pore structure or 
to the close vicinity of membrane-bound StnII. 
Most actinoporins contain five conserved Trp residues (Figure 1). At least two of 
them (W110 and W114 in StnII) have been shown to be part of an exposed and 
conserved cluster of aromatic residues which are implied in the interaction with 
membranes (8, 19, 37, 58, 91, 92). The present results showed that these two amino 
acids not only contribute to membrane binding but also insert into the hydrophobic 
region of the bilayer (Figure 5). This result is also in strong agreement with the previous 
hypothesis that the key role of membrane recognition assigned to the actinoporin’s 
tryptophan represented by W110 and W114 of StnII is based more on its participation in 
maintaining a hydrophobic effect that on the onset of interactions with specific SM 
chemical groups (58). The observed FRET indicates that CTL is located near W110 and 
W114. It could be argued, however, that the FRET with CTL does not originate from a 
specific interaction, but only from the abundance of CTL available at a short distance 
from the Trp indole side chains. It has been shown how Chol remains homogeneously 
distributed in the membrane in the presence of some Trp-flanked transmembrane 
peptides, and how the dynamics and orientation of neither Chol nor Trp located at the 
bilayer interface were influenced by the presence of the other molecule (67). However, 
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when we used a very similar approach, we observed the opposite effect (Figure 7). The 
FRET efficiency from W146 of StnII appeared above the theoretical curves, indicating 
that the acceptor (CTL) was preferentially distributed close to the donor (StnII). 
Because the distance measurements were based on a model obtained with detergents 
(19), we considered the interplanar distance to range from 26 to 28 Å. CTL preferential 
distribution near StnII held true even for the simulation of the limiting conditions, at 
which we assume that CTL can diffuse freely below W146 (Re = 0 Å), and the 
interplanar distance, h, is 26 Å. If the StnII pores contain lipids, then an exclusion 
distance should be considered, because lipids forming part of the pore would have a 
much lower diffusion rate and hinder diffusion of the remaining lipids near the 
complex. In that case, the theoretical FRET efficiency would be lower (Figure 7, long 
dashed lines). The comparatively large FRET efficiencies would then support CTL 
being part of such a lipid–protein complex. The model, regardless of the distance 
constraints that are used, overestimates the expected FRET efficiencies. It considers the 
FRET from the donor to anywhere around it, which, in the particular case of StnII 
pores, is not correct, because the pores themselves create a volume that cannot be 
transited by lipids.  
 
CONCLUSIONS 
Taken together, our results have shown that Chol and OCer behaved differently with 
regard to StnII-induced bilayer permeabilization. We speculate that head group 
orientation in SM clusters was different in the presence of Chol and OCer, and that the 
Chol-induced orientation was preferred by StnII. Since StnII activation in bilayers is 
markedly affected by hydrogen bonding (90), it is also possible that Chol and OCer 
rearranged SM hydrogen bonding differently, which in turn affected StnII-induced 
bilayer permeabilization. Such rearrangements of SM hydrogen bonding may also have 
affected SM head group orientation. Using FRET between Trp in StnII and the 
fluorescent Chol analog CTL in the bilayer, we were able to show that CTL displayed 
closest proximity to Trp in positions 100 and 114 of StnII. These two Trp positions are 
in the membrane binding region of StnII (Fig 1) which makes perfectly sense, and 
further support how StnII:s are oriented with regard to the bilayer. 
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FIGURES 
FIGURE 1. Cartoon representation of the expected orientation within the membrane of 
monomeric StnII (A) and its presumed membrane conformation when making an 
oligomeric pore (B). The location and side chains of all its Trp residues are also shown 
and are in purple. The diagram was constructed using the atomic coordinates deposited 
in the Protein Data Bank for monomeric StnII (1GWY) (14) and FraC octameric pores 
(4TSY) (19). A Chol molecule (salmon) is highlighted in the membrane. The image was 
generated with Chimera (93). 
FIGURE 2. The PyrSM E/M ratio as a function of various StnII concentrations. 
POPC:PSM:PyrSM (5:3:2) (○), POPC:PSM:PyrSM:OCer (5:3:2:1) (▲), or 
POPC:PSM:PyrSM:Chol (5:3:2:1) (●) LUVs were employed at a final phospholipid 
concentration of 1µM (approximate). The final stable E/M ratio was determined at 23 
°C, 10 min after the addition of the protein. PyrSM was excited at 345 nm; the 
monomer emission was read at 392 nm, and the excimer emission was monitored at 480 
nm. Each value is the average ± SEM (n = 2–3). 
FIGURE 3. Maximum rates of StnII induced the release of calcein entrapped in 
DOPC:SM:X (80:20:X) LUVs, containing different amounts (X) of Chol (○) or OCer 
(□). The StnII concentration was 10 nM in all experiments, and the protein/lipid molar 
ratio was maintained at 0.09. Calcein-entrapped vesicles were prepared via extrusion, 
and release was measured at 23 °C. All intensities were normalized. The maximum rate 
of release (∆F/sec was measured as the initial slope of the leakage curves) was 
measured by comparison with protein-free samples to which Triton X-100 was added to 
a final concentration of 0.05% v/v to induce LUV disintegration. The results shown are 
representative of three independent experiments. Each value is the average ± SEM (n = 
3). 
FIGURE 4. Analysis of the effect of StnII on the CTL relative quantum yield embedded 
in POPC:7-SLPC:PSM:CTL (50:30:20:5) (●) or (30:20:50:5) (▲) vesicles at different 
protein/lipid (P/L) molar ratios. This relative quantum yield change was expressed as 
the change, for each StnII concentration used, in the fluorescence emission. The 
excitation wavelength employed was 310 nm. CTL emission was recorded at 410 nm. 
All measurements were conducted at 23 ºC. Each value is the average ± SEM (n = 2). 
FIGURE 5. Fluorescence spectra of StnII WT and its different mutants used titrated 
with DOPC:eSM:Chol (1:1:1) LUVs. The panels at the right represent the relative 
quantum yield change as a function of the L/P ratio, using the quantum yield of StnII 
WT free in solution as reference. The excitation wavelength employed was 260 nm. The 
spectra were recorded at 25 ºC. The protein concentration was 200 nM in all 
experiments shown. Fluorescence intensities were normalized to 1.0 for the maximum 
emission of StnII WT in buffer, in the absence of vesicles. 
FIGURE 6. Fluorescence emission spectra of StnII WT and the Trp mutants studied in 
the absence or presence of DOPC:eSM:Chol:CTL (33:33:28:5) at a saturating L/P ratio 
of 93 (see Figure 5). The excitation wavelength employed was 260 nm, and the spectra 
were recorded at 25 ºC. The protein concentration was 200 nM in all experiments 
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shown. Fluorescence intensities were normalized to 1.0 for the maximum emission of 
StnII WT in buffer, in the absence of vesicles. 
FIGURE 7. Theoretically calculated FRET efficiency curves for StnII Trp146 side 
chains to CTL. The R0 of the FRET pair is 22.9 Å. The experimental values (dots) were 
calculated from fluorescence spectra of StnII W43/110/114/115F in vesicles composed 
of DOPC:eSM:sterol 1:1:1, with increasing amounts of CTL: 0.5, 1, 3, 5, and 8 mol%. 
FRET efficiencies were calculated for an L/P ratio of 93. Theoretical FRET values were 
calculated assuming a model based on the random distribution of the donor (StnII 
W43/110/114/115F) and the acceptor (CTL), and taking into account only the transfer 
to the cis leaflet (67). The distance between diffusion planes was considered to be 26–
28 Å, based on the location of the equivalent Trp residue in the crystalline structure of 
the FraC pore (PDB 4TSY) (19). Extreme conditions for interplanar and exclusion 
distances were simulated (Re = 0, h = 26 Å; short dashed line), showing that, even then, 
the experimental values were above the predictions for random distribution. As an 
example, other conditions were also simulated (Re = 10, h = 28 Å; long dashed line). 
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